United Therapeutics Corporation UTHR
$550.65▲ +0.10% 24H
Super Investor & Insider
1
Fondi che lo detengono
#1511
Rank consenso
1.4%
% dei portafogli
$207,543
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Mairs & Power · Mairs & Power | 0% | Buy | 350 | $207,543 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
United Therapeutics Corporation is a biotechnology company specializing in therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease, and other serious conditions. Founded in 1996 and headquartered in Silver Spring, Maryland, the company operates as a public b…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees1,400
TickerUTHR
Statistics
Market Cap$23.21B
Revenue (TTM)$3.18B
Net Income$1.33B
Net Margin41.9%
EPS$27.86
P/E20.17
P/S7.30
P/B3.90
EV/EBITDA13.56
ROE20.3%
Dividend Yield—
Price$550.65
Data: Twelve Data · Revenue = mcap / P/S